chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I was a little bit sick so the nurse said wait one week more for the second; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot number was not reported, Expiry date: Unknown) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient was a little bit sick so the nurse said wait one week more for the second. The outcome of the event was reported as unknown.  Follow-up attempts completed. No further information expected.
10 minutes post injection, patient complained of throat fullness and cough, became flush. Patient was examined by a Nurse who referred him to the Emergency department for further evaluation. Patient was hydrated with NS and medicated with diphenhydramine IV for throat swelling and Dexamethasone IV for cough.  Patient was monitored for about one hour until resolution of symptoms.
Received Varivax on thursday afternoon. Mom worked that evening. Child showed leg to Mom on Friday. Site was hot to the touch. At the site, it was red and swollen (Approx size ~2 inches). By Sunday, the reddened area had increased to 5 to 6 inches with a hard and raised area immedidately at the injection site. Mom used Tylenol, Benadryl  and warm packs to help relieve the discomfort, redness, and itching. Child was not taken into ER or clinic due to redness was starting to reduce by late Sunday nite. By Tuesday, Sept 4, all redness was gone except for minor discoloration at the injection site (resembles a bruise).
patient had itching of hands My symptoms were were primarily mild itching in the palms and throat and a rash on my chest and hands (was wearing a jacket and mask). On an itching scale of 1 to 10, I told them 2 to 3. According to my nurse, the rash on my chest and hands seemed to peak around 15-20 minutes after (not crimson) and when I finally got to go to the bathroom at the one hour mark and check myself in the mirror
Initial report received on 25 September 2007 from a health care provider. A 59-year-old female patient had received a right arm, subcutaneous injection of YF-VAX, lot number UF045AA; a right arm, intramuscular injection of Decavac, lot number U1950BA;' and a right arm, intramuscular injection of Hepatitis B Vaccine, manufacturer GSK, lot number AHBVB437cA; on 31 August 2007. Past medical history included a history of hepatitis A 30 years prior and travel to foreign countries. She had no illness at the time of vaccination. Other medication included Nexium. Two days post-vaccination, the patient called the vaccine provider to report a headache and nausea. These symptoms were treated with Tylenol. Fourteen days later, she again called complaining of continued nausea and weakness. The day after that, she was examined by a physician and was experiencing persistent nausea. Unspecified lab work was completed; and, per the reporter, the patient was found to have a "swollen liver." At the time of this report, the patient had not recovered.
Pruritic rash times 1 day. Positive papules on head, buttocks and thighs. Varicella vaccine 23 days ago.
I had the break through infection after 2 initial Moderna covid vaccinations; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (I had the break through infection after 2 initial Moderna covid vaccinations) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (I had the break through infection after 2 initial Moderna covid vaccinations). At the time of the report, COVID-19 (I had the break through infection after 2 initial Moderna covid vaccinations) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2022-689685 (Patient Link).
Bossy ache; Malaise; Fever; Chills; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot Number: ER8730), via an unspecified route of administration in the left arm on 29Mar2021 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension and atopic dermatitis. The patient did not have any allergies to food, medications, or other products. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: EN6206) via an unspecified route of administration in the left arm on 09Mar2021 at 11:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 29Mar2021 at 16:00, the patient experienced malaise, fever, chills, bossy ache and sore arm. The patient did not receive any treatment for the events malaise, fever, chills, bossy ache and sore arm. The clinical outcomes of the events malaise, fever, chills, bossy ache and sore arm were resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Extreme ringing in the ears, loud high pitch tone, starting 3 hours after receiving the booster shot. 24 hours later ringing still present and not improving.
About 20 minutes after administering the vaccine, I checked on the patient and she said she has chest pain. I asked our intern to stay with the patient while i called 911. The emergency crew arrived, completed the tests and advised to take her to the hospital. I called the mom later to check on her, mom told me that patient developed rash on her skin and throat. She was given oral Benadryl
It was reported that a 54 year old male patient received a TD Adult vaccination on 18 May 2000. Reportedly three days after the vaccination the patient developed an induration at the injection site, a fever and swelling of the arm from elbow to shoulder. Further information requested. From additional information received on 19 Jun 2000, it was reported that the patient recovered from this experience. Additional patient and responsible physician information was also provided.
I received my first dose of the Pfizer COVID19 vaccine on 5/18/21. Approximately two weeks later (around 6/1/21) I began to experience dizziness every time I stood up or changed positions. I had never experienced that before and suddenly started experiencing it multiple times a day every day. I received the second dose on 6/8/21. This side effect continued until around 6/15/21 and then went away.
Patient describes loss of consciousness and seizure like episode witnessed by her husband and lasting 10 minutes on the evening of the day she received the vaccine. EMS was called by husband, she declined transport to ER at that time and presented to a walk-in Express clinic 3 days later.
Developed rash on face and legs after vaccines. Rash noticed 1 hour after Hep B. Examined by MD and rs consistent with urticaria.
Patient returned with left upper arm swollen, red, warm to touch under injection site. Patient stated the red swollen arm on upper arm also itched.
Itchy rash and redness all over entire body.  Advised her to take Benedryl allergy and patient states the rash was gone by the next AM with no other adverse events.
This is a spontaneous report from a contactable consumer reporting for herself. A 41-year-old female patient received PREVNAR 13 via an unspecified route of administration single dose at left arm on 25Sep2017 10:00 for immunization, at the doctor's office. Medical history included ongoing asthma for 20 plus years. No family relevant medical history. There were no concomitant medications. No history of previous immunization. No additional vaccines administered on same date of the Pfizer suspect. No prior vaccinations (within 4 weeks). The patient was reporting the way the vaccine was injected. The vaccine was not injected in the back of her arm, but up high near shoulder bone on 25Sep2017 at 10:00. Immediately she had soreness and muscle pain for seven days. Felt like she was hit with a baseball bat. She also did not witness the Nurse assistant shake the vial before administration. The events muscle pain at injection site and soreness at injection site were recovered on an unknown date in 2017. No event required a visit to Emergency Room or Physician Office. The Doctor was not aware of events. No investigations performed. No treatments received. No relevant tests performed.
left arm was very sore; felt like her stomach was torn up; pain in the stomach; diarrhea; constipation; did not feel well; left arm was very sore; low grade fever of 99.5 degrees Fahrenheit; tired; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (felt like her stomach was torn up), ABDOMINAL PAIN UPPER (pain in the stomach), DIARRHOEA (diarrhea), CONSTIPATION (constipation) and MALAISE (did not feel well) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A and 028A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 20-Aug-2021, the patient experienced MALAISE (did not feel well), MYALGIA (left arm was very sore), PYREXIA (low grade fever of 99.5 degrees Fahrenheit) and FATIGUE (tired). On 22-Aug-2021, the patient experienced ABDOMINAL DISCOMFORT (felt like her stomach was torn up), ABDOMINAL PAIN UPPER (pain in the stomach), DIARRHOEA (diarrhea) and CONSTIPATION (constipation). On an unknown date, the patient experienced PAIN IN EXTREMITY (left arm was very sore). On 20-Aug-2021, PYREXIA (low grade fever of 99.5 degrees Fahrenheit) had resolved. On 26-Aug-2021, MALAISE (did not feel well), MYALGIA (left arm was very sore) and FATIGUE (tired) had resolved. At the time of the report, ABDOMINAL DISCOMFORT (felt like her stomach was torn up), ABDOMINAL PAIN UPPER (pain in the stomach), DIARRHOEA (diarrhea) and CONSTIPATION (constipation) had not resolved and PAIN IN EXTREMITY (left arm was very sore) outcome was unknown.            No Concomitant and Treatment medications were reported.
This case was reported by a physician and described the occurrence of a swollen area around the injection site in 5-year-old male subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine (DTPa, unknown manufacturer) for prophylaxis. The subject had no concomitant medications or relevant medical history. The subject's concurrent conditions were not reported. This subject had no adverse events following receipt of prior immunizations. On 11 April 2005, the subject received the 5th dose of DTPa (lot number, expiration date and route unknown). On an unspecified day in April 2005, after vaccination with DTPa on 11 April 2005, the subject developed an 8-10 inch area around the injection site that was red, swollen, painful and itchy. The subject's parent notified the physician's office and stated that topical diphenhydramine (Benadryl) did not work for the subject and oral Benadryl was going to be tried. The events resolved on an unknown date. Follow-up received on 26 July 2006 from the vaccine responsible physician indicated that the events were not serious and possibly related to the diphtheria and tetanus toxoids and acellular pertussis vaccine.
Pt pre-medicated with Benadryl and prednisone.  25 minutes after injection, started with itching at injection site, followed by facial flushing and redness, itching on chest.  Brought over to the ER for further evaluation.
Day after vaccine had extreme version of usual vaccine reactions, took Tylenol, still lingering effects the next day, extremely winded while trying to walk, several weeks later symptoms worsened. Extreme fatigue. 2 weeks after shot, was at elevation and extremely winded (usually not someone with respiratory issues). Missed work, drove to ER, lungs clotted. Doctor did not find any clot in legs, assumed it was Covid but did not have any other symptoms of Covid and negative covid test. 6 month recovery expected. Taking Xarelto coagulant, initially was on Eliquis, but responded poorly now on Xarelto.
ACUTE HYPOXEMIC RESPIRATORY FAILURE 8/31/2021 COVID-19 PNEUMONIA
Patient came today 9/30/19 to report that on the day of the vaccine after she got home her arm swelled up and she noticed a rash on the inection site. The next day her arm swelled up completely from shoulder to elbow She did cold compresses and Ibuprofen, she was fine after
Within 3 minutes of receiving vaccine a vasovagal response is noted to be occurring:  loss of vision, muffled sound, pale face, diaphoretic.  Normal function returned in 15 minutes.
-Electric feeling in my head- *brain zaps*  -Neck is tight and cold feeling, hurts to swallow  -Sleepiness  -Brain fog
Information has been received from a Registered Nurse concerning a 73 year old female patient with hypersensitivity to alendronate sodium and "bisphosphonat" who on 29-JAN-2008 was vaccinated IM into left arm with 0.5 mL of pneumococcal 23v polysaccharide vaccine (lot # 657525/0554U). The nurse reported that patient developed redness, tenderness, and swelling in the left arm after receiving the injection on 29-JAN-2008. The adverse symptoms developed on 30-JAN-2008 at the injection site covering a 4 centimeter area. The patient was examined on 30-JAN-2008 and was given ZYRTEC and ibuprofen. The patient was instructed to call back if the treatment was unsuccessful and she had not contacted the physician with further complaints. No other symptoms and no other information available. Additional information has been requested.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 10Feb2021 as dose 1, single (Lot number: El8982), in left arm and on 03Mar2021 as dose 2, single (Lot number: EN6203) at the age of 39 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 26Nov2021 as dose 3 (booster), single (Lot number: 067F21), in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: MILI [ETHINYLESTRADIOL; NORGESTIMATE], start date: 03May2021. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19; Negative, notes: and testing negative. Therapeutic measures were taken as a result of vaccination failure, covid-19.
Information has been received from a health professional concerning a 31 year old female who on 05/04/04 was vaccinated with a second dose of hepatitis B virus vaccine rHBsAG (yeast) (lot 644078/0940M). Subsequently the patient experienced elevated liver function tests. Unspecified medical attention was sought. There was no product quality complaint involved. No further information is available.
Got first shot of Moderna covid vaccine today. Sharp but very brief pain in arm at time of inoculation. During observation period, experienced numbness and tingling from tip of fingers to base of head on left side then had some tingling on tongue and a little numbness on lips. Lasted about an hour, nurse was excellent. Other than some fatigue and pain at injection site, not feeling much right now, 6 hrs post-shot
Case number PHHY2011US69614 is an initial spontaneous report received from health care professional on 29 Jul 2011. This case refers to an 11 year old female patient. She was vaccinated with MENVEO (batch number: M10034) 0.5ml intramuscularly on 26 Jul 2011. But, she was given only Men A conjugate vaccine reconstituted with a sterile diluent instead of Men CYW-135 liquid conjugate. No adverse reaction had occurred following this drug administration error.
Pt did not have any adverse events. She received the 2nd shot 12 days after the first. She will be given a 3rd vaccine 2 months after the most recent.
This spontaneous report was received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On an unknown date, the patients were vaccinated with improperly stored PEDVAXHIB injection, Lot number: M027884, expiration date: 19-APR-2019 (strength, dose, frequency and route of administration were not reported) vaccine, for prophylaxis with a temperature of >0 but < 2 degrees Celsius for 49 hours and 5 minutes. Additionally, this excursion was detected due to a digital data logger and there was no previous temperature excursion reported. No adverse symptoms reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA006818: US-009507513-1701USA006819.
On 09/01/2021 a Moderna vial was opened at approximately 05:30 PM, at closing of the business day (7pm) the Moderna vial was not removed from the refrigerator and discarded. Subsequently the vial was used the next day on 09/02/2021 at 03:07PM to vaccinate patient, approximately 9.5 hours past its 12 hour refrigerated expiration. The moderna vial was always kept refrigerated.
Chief complaint was breathing problem.  Dx of COVID-19. 79-year-old female, history of diabetes hypertension and hyperlipidemia, presenting with URI symptoms. Diagnosed covid positive, has been symptomatic for 5-6 days. Husband also known positive. Patient has been vaccinated remotely. Complains of some mild shortness of breath. Complains of a productive cough with discolored sputum. Body aches and fatigue. Patient not requiring oxygen, monitored in ED for over 5 hours. Referring patient to receive monoclonal antibody treatment. Told to return if symptoms acutely worsen.
Had lost of smell after having covid and it continues today after receiving the vaccine; Had lost of taste after having covid and it continues today after receiving the vaccine; soreness; was kind of feeling like coughing; not feeling good; body aches; (muscle pain) like somebody punching the arm; muscle pain; pain at the injection site; chills; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Had lost of smell after having covid and it continues today after receiving the vaccine), AGEUSIA (Had lost of taste after having covid and it continues today after receiving the vaccine), PAIN (soreness), COUGH (was kind of feeling like coughing) and FEELING ABNORMAL (not feeling good) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 15-Jul-2021. Concurrent medical conditions included Smell loss (Lost sense of smell) and Taste loss (Lost sense of taste). Concomitant products included VITAMINS NOS and NAPROXEN SODIUM (COMPLEMENT) for an unknown indication.    On 05-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Aug-2021, the patient experienced PAIN (soreness), COUGH (was kind of feeling like coughing), FEELING ABNORMAL (not feeling good), PAIN (body aches), PAIN IN EXTREMITY ((muscle pain) like somebody punching the arm), MYALGIA (muscle pain), VACCINATION SITE PAIN (pain at the injection site) and CHILLS (chills). On an unknown date, the patient experienced ANOSMIA (Had lost of smell after having covid and it continues today after receiving the vaccine) and AGEUSIA (Had lost of taste after having covid and it continues today after receiving the vaccine). On 07-Aug-2021, PAIN (soreness), COUGH (was kind of feeling like coughing), FEELING ABNORMAL (not feeling good), PAIN (body aches), PAIN IN EXTREMITY ((muscle pain) like somebody punching the arm), MYALGIA (muscle pain), VACCINATION SITE PAIN (pain at the injection site) and CHILLS (chills) had resolved. At the time of the report, ANOSMIA (Had lost of smell after having covid and it continues today after receiving the vaccine) and AGEUSIA (Had lost of taste after having covid and it continues today after receiving the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were provided by the reporter.
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 05-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). On 05-Apr-2021, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.            Action taken with mRNA-1273 in response to the events was not applicable. Patient calling after receiving the second dose of the Moderna Covid 19 vaccine on 5Apr2021. She states that she just found out she was pregnant.
Irregular menstruation; This spontaneous case was reported by a patient and describes the occurrence of MENSTRUATION IRREGULAR (Irregular menstruation) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MENSTRUATION IRREGULAR (Irregular menstruation). At the time of the report, MENSTRUATION IRREGULAR (Irregular menstruation) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Febrile seizure, temp 103-day after vaccine. ER-Bld wk NL. CT brain and mild ventriculomegally next day in office positive strep.
pt recvd vax; devel varicella like rash & 30 lesions on legs;
Mom contacted me 3/30/05 reporting significant swelling beginning in left deltoid were #5 DTaP was administered on 3/28/05. She states comparing his right deltoid to his left; the right delt measures 7.5" circumference and his left measures 10" circumference.  She states swelling has moved below the elbow.  She spoke to her son's physician who approved administration of Benadry chewables as package insert for child's age and repeating the dosage as package insert directs.  She did administer the 1st dose of Benadryl prior to our conversation.  She is also tracking the changes in swelling by noting time and date in ink on child's arm.